SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-004199
Filing Date
2017-03-14
Accepted
2017-03-14 07:00:19
Documents
3
Period of Report
2017-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ATRS-8K-20170314 EARNINGS RELESE atrs-8k_20170314.htm 8-K 31141
2 EX-99.1 ATRS EARNINGS RELEASE atrs-ex991_6.htm EX-99.1 329137
3 GRAPHIC g2017031402294642134615.jpg GRAPHIC 17898
  Complete submission text file 0001564590-17-004199.txt   386491
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 17686884
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10